glucocorticoids Flashcards
adrenal gland components
- adrenal cortex: secrete glucocorticoids and mineralocorticoids
- adrenal medulla: epinephrine and norepinephrine
anterior pituitary ACTH stimulates glucocorticoids release
- mainly cortisol
- drugs given mimic cortisol
glucocorticoids physiology
- promote glucose availability - protein metabolism
- fat metabolism
- cardiovascular: support SNS activity on blood vessels
over secretion of glucocorticoids
cushing syndrome
under secretion of glucocorticoids
addison’s disease (autoimmune of adrenal cortex)
glucocorticoids example
- prednisone: drug of choice of oral glucocorticoids for anti-inflammatory purposes and hormone replacement
- prednisolone
- cortisone
- dexamethasone
all mimic cortisol
dose for hormone replacement much lower than dose for immunosuppressant
glucocorticoids given by:
- inhalation: asthma/COPD
- nasally: rhinitis, prevent recurrence of polyps
- topically: inflammation of eye, ear, skin
- systemic (IV, PO): hormone replacement and immunosuppression
glucocorticoids moa
alter gene expression of many proteins
- physiological doses (low: hormone replacement)
- pharmacological doses (high: inmunosupresion)
glucocorticoids help control inflammatory and immune responses
- cytokines (IL-2), COX, inhibit immune cell proliferation
glucocorticoids indications
- adrenocortical deficiency (addison’s disease): lifelong replacement therapy
- anti-inflammatory/immune suppression: COPD, asthma, organ transplant, GI diseases, dermatological diseases
glucocorticoids contraindications
serious infections ongoing
- systemic fungal infections
- body cannot fight
glucocorticoids cautions
- GI issues: provoke PUD, reflux, gastritis
- high doses increase glucose levels in plasma: diabetes mellitus
- CV: HTN, HF, renal impairment, pregnancy
glucocorticoids AE
mimic cushing’s syndrome
- moon face
- buffalo hump (fat deposit on neck)
- abdominal fat
- thin arms and legs
- stria (red markings)
CV: HF, edema, HTN
CNS: convulsions, headache, vertigo, mood swings, nervousness, insomnia, steroid psychosis
endocrine: growth suppression, cushings, menstrual irregularities, carb intolerance, hyperglycemia
GI: ulcers, perforation, distension, pancreatitis
Integumentary: skin thinning
musculoskeletal: muscle weakness, loss of muscle mass
AE depends on dosage
replacement therapy doses do not produce cushing’s syndrome
higher doses for inflammation or immune suppression major AE are more common (must have shorter term use)
replacement therapy
lifelong treatment may need to increase dosage in times of stress
- infections, surgery, traumas
- simulating what happens physiologically
- 3x3 rule: three times usual dose for 3 days
immunosuppressant therapy
drug inhibits physiological control of cortisol secretions
- reduced/absent ACTH and CRH
- negative feedback
- leads to cortex atrophy (nonfunctional)
- tapering of doses when coming off drugs allow adrenal cortex to recover
- inhibition on ant pit reduced step by step, ACTH levels rise, stimulate adrenal cortex so it is functional, produce natural cortisol again
client implication
sudden discontinuation of glucocarticoids can precipitate an adrenal crisis
- adrenal gland cannot make glucocorticoids
- abdominal pain
- low BP, dehydration (shock, fatal)
- N&V
- extreme fatigue
- confusion, convulsions
taper doses before drug is discontinued